294. From ICU Monitors to AI Twins: How Retia Is Advancing Hemodynamic Monitoring With AI

Episode breakdown:00:00 – Welcome to the State of Medtech Podcast 00:28 – Introducing Marc Zemel, CEO of Retia Medical 01:05 – Marc Zemel’s Background and Journey to Medtech 02:09 – The Problem Retia Set Out to Solve 02:59 – From Concept to Commercialization: Retia's Path to FDA & Medtronic Partnership 03:44 – Retia’s Primary Use Case: High-Risk Surgeries & ICU 05:00 – Why Accurate Hemodynamic Monitoring Saves Lives 06:43 – AI, Plug-and-Play Design, and Clinician Usability 08:01 – Reducing Clinician Friction with Seamless Integration 09:45 – Alarm Fatigue in the ICU and Retia’s Visual-First Approach 10:55 – Why Retia Is Transitioning to Software as a Medical Device (SaMD) 13:00 – Breaking the Razor Blade Model in Medtech 14:43 – Inside Argos Infinity: Hospital-Wide Remote Monitoring in Action 16:23 – The Future of Clinical Intelligence Platforms 18:03 – Moving Beyond Screens: Retia’s Digital Health Vision 20:37 – Retia’s SaMD Business Model: From Pilot to Platform 22:00 – Acute Kidney Injury and the Economics of Prevention 24:05 – Recurring Revenue and the Power of Per-Bed Pricing 26:00 – Why You Can’t Monitor What You Don’t Measure 27:28 – Retia’s Work with Johns Hopkins: AI and Predictive Outcomes 28:53 – The Growing Role of Cybersecurity in SaMD 30:45 – The SaaS Advantage: Push Updates, Lower COGS, Higher Margins 32:00 – The Rise of the Medtech Algorithm Economy 33:44 – Will Big Tech (Apple?) Enter Medtech Through Acquisitions? 35:00 – iOS vs Android: Who Will Build the Medtech Ecosystem? 36:42 – Strategic Acquirers: Who Might Buy Retia? 38:47 – Closing Thoughts: Building a Physiologic Twin for Critical Care 40:22 – Outro: Where to Learn More About Retia Medical Don’t Let Cybersecurity Risks Delay Your Medical Device Premarket Approval. Check out BlueGoatCyber.comAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.